3rd Quarter - Report

BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Opioid Addiction Crisis S.916- Protecting Patient Access to Emergency Medications Act of 2017

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 916 (115th)

Medicare/Medicaid MMM

Opioid Addiction Crisis S.916- Protecting Patient Access to Emergency Medications Act of 2017

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 916 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.